About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Notice of 2015 Annual General Meeting

April 22, 2015

Click here to read more

Post navigation

Appendix 3X Notices – Three New Directors

2014 Annual Report

Related Posts

Ethics Approval to Commence Topical TPM®/Oxycodone Patch Trial

December 8, 2014

Reformulation of Phosphagenics Transdermal TPM/Oxymorphone Patch Complete

December 12, 2016

Voluntary Withdrawal from OTCQX

December 3, 2018

Recent Posts

Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
Dosing commences for Phase I human clinical trial
October 4, 2021
Biotech Webinar
September 23, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.